U.S. Markets open in 10 mins

Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled

ALLISON GATLIN
Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled

Array stock popped in high volume Tuesday after its colon cancer treatment showed promise in a Phase 3 study. Array stock hit a record high and closed well above its 50-day moving average.